Correction of metabolic disorders in patients co-infected with HIV/HCV
<p>There was studied an effectiveness of phosphogliv in correction of metabolic disorders in patients co-infected with HIV\HCV.</p><p><strong>Methods</strong><strong>:</strong><strong> </strong>There were examined 40 patients co-infected with HIV...
Main Authors: | Володимир Миколайович Козько, Катерина Володимирівна Юрко, Ганна Олегівна Соломенник |
---|---|
Format: | Article |
Language: | English |
Published: |
PC Technology Center
2015-10-01
|
Series: | ScienceRise |
Subjects: | |
Online Access: | http://journals.uran.ua/sciencerise/article/view/51664 |
Similar Items
-
Prevalence of TLR-4 gene polymorphism in patients co-infected with HIV/HCV
by: Катерина Володимирівна Юрко
Published: (2015-11-01) -
Impact of HCV Eradication on Lipid Metabolism in HIV/HCV Coinfected Patients: Data from ICONA and HepaICONA Foundation Cohort Study
by: Martina Spaziante, et al.
Published: (2021-07-01) -
Administration of phospholipide hepatoprotective drug Phosphogliv in patients with psoriatic arthritis (preliminary results)
by: T. V. Korotaeva, et al.
Published: (2004-06-01) -
MicroRNA Profile of HCV Spontaneous Clarified Individuals, Denotes Previous HCV Infection
by: Óscar Brochado-Kith, et al.
Published: (2019-06-01) -
Molecular Mechanisms of Liver Fibrosis in HIV/HCV Coinfection
by: Claudio M. Mastroianni, et al.
Published: (2014-05-01)